Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 324

1.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de Groot E; ENHANCE Investigators..

N Engl J Med. 2008 Apr 3;358(14):1431-43. doi: 10.1056/NEJMoa0800742. Erratum in: N Engl J Med. 2008 May 1;358(18):1977.

2.

Extended-release niacin or ezetimibe and carotid intima-media thickness.

Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L, Miller M, Weissman NJ, Turco M.

N Engl J Med. 2009 Nov 26;361(22):2113-22. doi: 10.1056/NEJMoa0907569.

4.

Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.

Avellone G, Di Garbo V, Guarnotta V, Scaglione R, Parrinello G, Purpura L, Torres D, Campisi D.

Int Angiol. 2010 Dec;29(6):514-24.

PMID:
21173733
5.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Diamond GA, Kaul S.

N Engl J Med. 2008 Jul 31;359(5):530; author reply 532. No abstract available.

PMID:
18677796
6.

Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin.

de Sauvage Nolting PR, de Groot E, Zwinderman AH, Buirma RJ, Trip MD, Kastelein JJ.

Arch Intern Med. 2003 Aug 11-25;163(15):1837-41.

PMID:
12912721
8.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators..

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489.

9.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Connor WE.

N Engl J Med. 2008 Jul 31;359(5):530; author reply 532-3. No abstract available.

PMID:
18677797
10.

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.

Kastelein JJ, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE, Riley WA, Shear CL, Duggan WT, Bots ML; RADIANCE 1 Investigators..

N Engl J Med. 2007 Apr 19;356(16):1620-30.

11.

Cholesterol lowering and ezetimibe.

Drazen JM, Jarcho JA, Morrissey S, Curfman GD.

N Engl J Med. 2008 Apr 3;358(14):1507-8. doi: 10.1056/NEJMe0801842. No abstract available.

12.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Eichhorn EJ.

N Engl J Med. 2008 Jul 31;359(5):529-30; author reply 532. No abstract available.

PMID:
18677795
13.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Steinberg D.

N Engl J Med. 2008 Jul 31;359(5):529; author reply 532. doi: 10.1056/NEJMc080981. No abstract available.

14.

Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?

Brown BG, Taylor AJ.

N Engl J Med. 2008 Apr 3;358(14):1504-7. doi: 10.1056/NEJMe0801608. No abstract available.

15.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Blake JA.

N Engl J Med. 2008 Jul 31;359(5):531; author reply 532-3. No abstract available.

PMID:
18677798
17.

Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial.

Goldberg AC, Sapre A, Liu J, Capece R, Mitchel YB; Ezetimibe Study Group..

Mayo Clin Proc. 2004 May;79(5):620-9.

PMID:
15132403
18.

The VYtorin on Carotid intima-media thickness and overall arterial rigidity (VYCTOR) study.

Meaney A, Ceballos G, Asbun J, Solache G, Mendoza E, Vela A, Meaney E.

J Clin Pharmacol. 2009 Jul;49(7):838-47. doi: 10.1177/0091270009337011.

PMID:
19443679
19.
20.

Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia.

Gagné C, Gaudet D, Bruckert E; Ezetimibe Study Group..

Circulation. 2002 May 28;105(21):2469-75.

Items per page

Supplemental Content

Support Center